EurekaMag
+ Most Popular
Cunninghamia lanceolata plantations in China
Mammalian lairs in paleo ecological studies and palynology
Studies on technological possibilities in utilization of anhydrous milk fat for production of recombined butter-like products
Should right-sided fibroelastomas be operated upon?
Large esophageal lipoma
Apoptosis in the mammalian thymus during normal histogenesis and under various in vitro and in vivo experimental conditions
Poissons characoides nouveaux ou non signales de l'Ilha do Bananal, Bresil
Desensitizing efficacy of Colgate Sensitive Maximum Strength and Fresh Mint Sensodyne dentifrices
Administration of fluid by subcutaneous infusion: revival of a forgotten method
Tundra mosquito control - an impossible dream?
Schizophrenia for primary care providers: how to contribute to the care of a vulnerable patient population
Geochemical pattern analysis; method of describing the Southeastern limestone regional aquifer system
Incidence of low birth weights in a hospital of Mexico City
Tabanidae
Graded management intensity of grassland systems for enhancing floristic diversity
Microbiology and biochemistry of cheese and fermented milk
The ember tetra: a new pygmy characid tetra from the Rio das Mortes, Brazil, Hyphessobrycon amandae sp. n. (Pisces, Characoidei)
Risk factors of contrast-induced nephropathy in patients after coronary artery intervention
Renovation of onsite domestic wastewater in a poorly drained soil
Observations of the propagation velocity and formation mechanism of burst fractures caused by gunshot
Systolic blood pressure in a population of infants in the first year of life: the Brompton study
Haematological studies in rats fed with metanil yellow
Studies on pasteurellosis. I. A new species of Pasteurella encountered in chronic fowl cholera
Dormancy breaking and germination of Acacia salicina Lindl. seeds
therapy of lupus nephritis. a two-year prospective study

Newer approaches to the therapy of multiple myeloma


Newer approaches to the therapy of multiple myeloma



Blood 76(9): 1678-1679



ISSN/ISBN: 0006-4971

PMID: 1699619


Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 040805503

Download citation: RISBibTeXText

Related references

Newer approaches to the management of multiple myeloma. Cancer 72(11 Suppl): 3489-3494, 1993

Multiple myeloma. new approaches to therapy. JAMA 269(18): 2412-2416, 1993

Gene therapy approaches for multiple myeloma. Seminars in Hematology 38(3): 268-275, 2001

MUKnine OPTIMUM protocol: a screening study to identify high-risk patients with multiple myeloma suitable for novel treatment approaches combined with a phase Ii study evaluating optimised combination of biological therapy in newly diagnosed high-risk multiple myeloma and plasma cell leukaemia. Bmj Open 11(3): E046225, 2021

Current and future approaches to therapy for multiple myeloma. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 22(1): 9-15, 1995

Antibody therapy for multiple myeloma: novel approaches and future perspectives. Japanese Journal of Clinical Hematology 61(8): 912-921, 2020

High-dose therapy and innovative approaches to treatment of multiple myeloma. Seminars in Hematology 38(2 Suppl 3: 21-27, 2001

Developments in continuous therapy and maintenance treatment approaches for patients with newly diagnosed multiple myeloma. Blood Cancer Journal 10(2): 17, 2020

Consensus statement from European experts on the diagnosis, management, and treatment of multiple myeloma: from standard therapy to novel approaches. Leukemia and Lymphoma 51(8): 1424-1443, 2010

Challenging the current approaches to multiple myeloma- and other cancer-related bone diseases: from bisphosphonates to targeted therapy. Leukemia and Lymphoma 53(6): 1057-1061, 2012

Multiple Myeloma: Introduction: Multiple Myeloma Current Approaches. Cancer Investigation 15(1): 55-56, 1997

Bortezomib, thalidomide, dexamethasone induction therapy followed by melphalan, prednisolone, thalidomide consolidation therapy as a first line of treatment for patients with multiple myeloma who are non-transplant candidates: results of the Korean Multiple Myeloma Working Party (KMMWP). Annals of Hematology 89(5): 489-497, 2010

Newer therapeutic molecules for multiple myeloma. Indian Journal of Cancer 45(4): 142-148, 2008

Clinical studies on chemo therapy for multiple myeloma 1. response rates and survival times in multiple myeloma treated with melphalan and ifosfamide. Okayama Igakkai Zasshi 93(5-6): 507-518, 1981

Clinical studies on chemo therapy for multiple myeloma 2. response rates prognostic factors and side effects in multiple myeloma treated with prednisolone and sequential melphalan and ifosfamide. Okayama Igakkai Zasshi 93(5-6): 519-536, 1981